Course Directors: Mary Lynn McPherson, PhD
This website contains new education (presentation and posters) along with previously recorded presentations from thought leaders in the field of opioids at past ICOO conferences. They have been selected due to the timeless nature of their presentation and education value.
Objectives: After attending this meeting participants should be able to:
•Describe the enhanced therapeutic benefits of various opioids and highlight indications for use in chronic and cancer pain.
•Explain various prescribing guidelines for treatment of pain, limiting the abuse of prescription opioid analgesics by carrying out the current prescription guidelines.
•Identify, diagnose, treat, or refer a patient with drug addiction.
•Recognize the legal and regulatory implications of prescribing opioids that arise when treating individuals in pain.
•Identify the basic pharmacology of new and existing opioids, and utilize and promote evidence-based approaches for clinical treatment.
•Describe the development of new sciences and explain the differences among formulations, including specific short-acting versus long-acting opioid analgesics.
Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Final accreditation is in process. This website contains new education along with previously recorded presentations from thought leaders in the field of opioids.
We are working to secure accreditation for the important education contained on this virtual conference. We offer this special rate to be able to view the video learning on this website. If/when we secure CMEs for this site, registered attendees will be sent a link to complete their post test and claim their credit at no additional cost.
The Accreditor designates this live activity for a maximum of TBD AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for TBD hours of risk management study.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for TBD hours of opioid education.
Contact Hours: TBD, of which TBD are pharmacology credit worthy.
CPE Credit: The University of Maryland College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This is a knowledge-based educational activity.
Universal Activity Numbers (UAN) are as follows: TBD
Disclaimer: THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY OR WESTON MEDICAL PUBLISHING, LLC, BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.
Off Label Statement: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The faculty have been asked to disclose this information when presented. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Cancellations: Should you be unable to attend, please inform us in writing prior to May 1, 2020 and a full refund less a 25% non-refundable deposit will be issued. No refunds or credits will be given for cancellations received on or after May 2, 2020. Substitutions of enrolled registrants must be made in writing. If for any reason this conference is cancelled, the conference organizers and sponsors do not accept responsibility for covering airfare, hotel or other costs incurred by conference registrants. The speakers and agenda of this program are subject to change without notice due to unforeseen circumstances beyond the control of conference presenters.
ADA Support: Weston Medical Publishing, LLC fully comply with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact our offices at 781-899-2702 Ext. 108 in order to receive services.
The Journal of Opioid Management presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
The speakers and agenda of this program are subject to change without notice due to unforeseen circumstances beyond the control of conference presenters.